Clinical Trials Browser

Enrolling by invitation × Neoplasms × 90 days × Clear all

NCT00068003 2026-04-14

Harvesting Cells for Experimental Cancer Treatments

Enrolling by invitation

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms

NCT00923065 2026-04-14

Data Collection, Clinical Care and Interventions in CCR, NCI

Enrolling by invitation

10,000 enrolled

Neoplasms

NCT02154022 2026-04-14

Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity

Enrolling by invitation

Neoplasms

NCT06763770 2026-04-13

Digital Self-Management and Peer Mentoring Intervention

Phase NA Enrolling by invitation

Neoplasms

NCT06788509 2026-04-13

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Phase 1 Enrolling by invitation

GenitourinaryLymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Prostatic Neoplasms, Castration-Resistant

NCT00027326 2026-04-08

Collection of Blood and Urine From Patients Undergoing Radiation Therapy

Enrolling by invitation

Carcinoma, Neoplasms

NCT04450927 2026-04-08

Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Enrolling by invitation

10,000 enrolled

Hematologic Diseases, Neoplasms

NCT07517666 2026-04-08

GIFTT

Phase NA Enrolling by invitation

Neoplasms

NCT05407844 2026-04-06

DeCIDE PC

Phase NA Enrolling by invitation

Neoplasms

NCT06699615 2026-04-06

Assessing Perceptions of ML Explanations by Medical Oncologists

Phase NA Enrolling by invitation

Neoplasms

NCT06709040 2026-04-06

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Enrolling by invitation

Diabetes Mellitus, Type 2, Dwarfism, Pituitary, Neoplasms

NCT03432936 2026-04-01

Prospective Use of Philips iSuite for Interventional Procedures

Phase NA Enrolling by invitation

Neoplasms

NCT06296641 2026-04-01

Cope-CAYAC

Phase NA Enrolling by invitation

Neoplasms

NCT05303532 2026-03-24

ROSY-D

Phase 3 Enrolling by invitation

Neoplasms

NCT06089954 2026-03-24

ROR

Phase NA Enrolling by invitation

Cardiovascular Diseases, Neoplasms, Genetic Diseases, Inborn

NCT03610906 2026-03-23

Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy

Enrolling by invitation

Craniopharyngioma, Neoplasms

NCT07218003 2026-03-23

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Phase 1 Enrolling by invitation

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT07226180 2026-03-18

Development and Application of Patient-Derived Models of Cancer

Enrolling by invitation

Neoplasms

NCT06645093 2026-03-10

FasteStudien

Phase NA Enrolling by invitation

Intermittent Fasting, Fasting, Lymphoma, Neoplasms

NCT07026370 2026-03-05

CPHMS

Enrolling by invitation

50,991 enrolled

Cerebrovascular Disorders, Metabolic Diseases, Neoplasms

NCT05948618 2026-03-04

ECA-PRO Aim 3

Phase NA Enrolling by invitation

Neoplasms, Medication Adherence

NCT04996706 2026-02-27

LEO

Enrolling by invitation

21,000 enrolled

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT07422727 2026-02-20

COOLVAS

Phase NA Enrolling by invitation

Neoplasms, Hot Flashes

NCT06412029 2026-02-19

HRSN

Enrolling by invitation

Neoplasms

NCT05879211 2026-02-12

Goal Concordant Care Learning Laboratory

Phase NA Enrolling by invitation

Dementia, Heart Failure, Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT06701201 2026-02-10

A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product

Enrolling by invitation

Neoplasms

NCT04357574 2026-02-06

CORONA-SHIELD

Enrolling by invitation

COVID-19, Neoplasms

NCT07057284 2026-01-26

DENTOFACIAL-PBT Stage 2 - Feasibility Study

Enrolling by invitation

Congenital Abnormalities, Developmental Disabilities, Head and Neck Neoplasms, Neoplasms, Radiation Injuries